EUVIMEDEUVIMED entdecken
Crossref

Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage

Yan Yan, Jianhong Xia, Tingting Ma, Liqing Zhou iD

Advanced Biology · 2026-04 · 10 (4)

DOI: 10.1002/adbi.202500715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 07.04.2026. Verfasst von Yan Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, Chi…. Hauptthemen laut MEDLINE: MicroRNAs, Cisplatin, DNA Damage, Breast Neoplasms. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To elucidate how ALX Homeobox 4 (ALX4) modulates cisplatin sensitivity via DNA damage regulation in breast cancer (BC), this study explored the established role of mRNA‐mediated DNA repair in driving chemoresistance.

Methods

Integrated bioinformatics and molecular experiments identified ALX4 and miR‐301b‐3p expression patterns in BC cells. Potential binding sites between them were predicted and verified by dual‐luciferase assays. Cellular experiments determined cisplatin IC50 via CCK‐8 assays, while functional impacts of the miR‐301b‐3p/ALX4 axis on proliferation, apoptosis, and cisplatin‐induced DNA damage were assessed using CCK‐8, flow cytometry, alkaline comet assays, and western blot.

Results

Our study identified downregulated ALX4 and upregulated miR‐301b‐3p in BC tissues. miR‐301b‐3p directly targeted ALX4, as confirmed by dual‐luciferase assays. Overexpression of ALX4 inhibited BC cell proliferation, promoted apoptosis, enhanced cisplatin‐induced DNA damage, and increased cisplatin sensitivity. Conversely, miR‐301b‐3p negatively regulated ALX4, thereby modulating DNA damage and cellular response to cisplatin.

Conclusion

This study demonstrates that miR‐301b‐3p promotes BC proliferation and reduces cisplatin sensitivity by suppressing ALX4, a mechanism mediated through the regulation of DNA damage pathways. These findings offer new insights into cisplatin resistance and suggest potential therapeutic targets for overcoming chemoresistance in BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCisplatinDNA DamageBreast NeoplasmsDrug Resistance, NeoplasmHomeodomain ProteinsTranscription FactorsHumansFemaleGene Expression Regulation, NeoplasticCell ProliferationApoptosisCell Line, TumorAntineoplastic Agents

Stichwörter der Autor:innen

ALX4DNA damagebreast cancercisplatin resistancemiR‐301b‐3p

Substanzen

MicroRNAsCisplatinMIRN301A microRNA, humanHomeodomain ProteinsAntineoplastic AgentsTranscription Factors

Autor:innen und Institutionen

  • Radiotherapy Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China.

ORCID-Profile: Liqing Zhou

Zitieren

APA

Yan, Y., Xia, J., Ma, T., & Zhou, L. (2026). Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage. Advanced Biology, 10(4). https://doi.org/10.1002/adbi.202500715

Vancouver

Yan Y, Xia J, Ma T, Zhou L. Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage. Advanced Biology. 2026;10(4). doi:10.1002/adbi.202500715

BibTeX
@article{Yan2026,
  author = {Yan, Yan and Xia, Jianhong and Ma, Tingting and Zhou, Liqing},
  title = {Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage},
  journal = {Advanced Biology},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1002/adbi.202500715}
}
Kostenlos starten →